Sponsor content
213 result(s) found, displaying 71 to 80
-
Australian public assessment report (AusPar)New AusPAR for ACTEMRA Tocilizumab (rch) for the treatment of coronavirus disease 2019 (COVID-19).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOFLUZA baloxavir marboxil 40 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: tocilizumab.
-
Prescription medicine registrationActive ingredients: casirivimab; imdevimab.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Pertuzumab/trastuzumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for POLIVY polatuzumab vedotin 140 mg powder for injection vial.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Risdiplam
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Satralizumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECENTRIQ atezolizumab (rch) 840 mg/14 mL injection concentrated vial.